AI-generated summary
The authors compared a non-ablative 1550-nm erbium-doped fractional laser with an ablative 10 600-nm carbon dioxide fractional laser in a split-face study of eight patients with acne scars, with evaluators blinded to treatment. At 3 months, mean improvement grades were 2.0 for the erbium laser and 2.5 for the carbon dioxide laser, with less crusting, erythema and pain reported for the erbium side.
- Participants
- 8
- Who or what was studied
- Eight East Asian patients with acne scars
- Wavelengths
- 1550 nm
- Limits stated in the abstract
- The sample of eight patients is very small, and the abstract reports no control group beyond the paired split-face design.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Visual analogue scale, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.